Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises AmSpec in connection with the acquisition of IIS
Mandate

Vinge advises AmSpec in connection with the acquisition of IIS

February 06, 2023 Employment and Benefits Intellectual Property M&A Real Estate and Construction IT, Telecommunications and Outsourcing Data protection and processing of personal data Commercial Agreements

AmSpec Group, Inc., together with its subsidiaries (“AmSpec”), is a multinational group of companies within inspection, analysis and testing of products in the energy- and agricultural industries.

IIS Independent Inspection Services AB (“IIS”) conducts testing, inspection and a range of support services to the energy- and agricultural sectors in the Nordic market. The company has its main laboratory in Gothenburg.

The acquisition of IIS strengthens AmSpec’s position in the European market in general, and in the Nordic market in particular.

Vinge’s team mainly consisted of Jonas Johansson, Viktor Lennartsson, Robin Sultani (M&A), Karin Gynnerstedt (employment), Christoffer Nordin (commercial agreements), Karolina Fuhrman (IT and GDPR), Arvid Axelryd (IP), Markus Bernander (real estate), Ottilia Pettersson and Ellinore Boström Andersson (project assistants).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025